Facebook
Twitter
LinkedIn
Forward
2019 DF/BWCC Network Education Day
The course is designed to give medical oncologists, radiation oncologists, and midlevel providers updated information regarding the management of a broad spectrum of cancer types. The primary audience for this activity are oncologists practicing in a community-based setting. In this setting, general oncologists are in need of up-to-date information on the management of a variety of common and less-common cancer types and are limited in their ability to develop an in-depth expertise on any one diagnosis.
Our annual network education day proposes to provide practitioners knowledge in the current state of the science in the management and prevention of cancers, thus addressing the gap in knowledge. Moreover, through lectures, case-based presentations, and Q & A, our faculty put this knowledge base into the context of clinical practice to allow practitioners to integrate this knowledge into routine clinical practice, addressing a gap in learner competence and performance
Target Audience
This activity is intended for medical and radiation oncologists as well as mid-level providers (i.e. nurse practitioners and physician assistants) from DFCI and DF/BWCC network locations including satellites and community practices, in addition to medical and radiation oncologists from regional affiliates including members of the "DF/BWCC Cancer Care Collaborative" (Stamford Hospital, Berkshire Medical Center, Eastern Maine Medical Center, UMass Memorial Medical Center, Cape Cod Hospital, New England Cancer Specialists), Lifespan Cancer Institute, Steward healthcare, Bermuda Cancer and Health Centre.
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Identify the most recent management and treatment options for some of the cancer types that are most commonly seen in the community. Specifically, participants will have a more in-depth and up-to-date understanding of:
- Renal Cell Carcinoma, specifically, immuno-oncology approaches to treatment
- Colon Cancer, specifically updates in therapy and recent studies
- Ovarian Cancer, specifically updates in therapy and recent studies
- Non-Hodgkin Lymphoma, specifically updates in therapy and recent studies
- Lung Cancer, specifically, recent considerations with respect to targeted therapies
- HER 2+ Breast Cancer, specifically updates in therapy and recent studies
2. Recognize appropriate approaches and best practices with respect to palliative care and pain control for their patients
3. Discuss the most recent advances in radiation oncology, specifically:
- Radiation therapy updates for Prostate Cancer
- Multimodality therapy with Immunotherapy and Radiation
Additional Information
Dana-Farber/Brigham and Women's Cancer Center and Partners HealthCare System
Harold J. Burstein, MD, PhD - Course Director
Associate Professor, Medicine, Harvard Medical School;
Staff Physician, Medicine, Brigham And Women's Hospital
Lauren Harshman, MD
Assistant Professor of Medicine, Harvard Medical School;
Senior Physician, Dana-Farber Cancer Institute
Ann LaCasce, MD, MMSc
Institute Physician; Associate Professor of Medicine, Harvard Medical School;
Director, Dana-Farber/Partners CancerCare Hematology-Medical Oncology Fellowship Program,
Dana-Farber Cancer Institute
Kate Lally, MD
Instructor in Medicine, Harvard Medical School;
Senior Physician, Palliative Care,
Dana-Farber Cancer Institute
Joyce Liu, MD, MPH
Assistant Professor of Medicine, Harvard Medical School;
Director, Clinical Research, Division of Gynecologic Oncology,
Physician, Dana-Farber Cancer Institute
Erica Mayer, MD, MPH
Assistant Professor of Medicine, Harvard Medical School;
Senior Physician, Dana-Farber Cancer Institute
Kimmie Ng, MD, MPH
Associate Professor of Medicine, Harvard Medical School;
Co-Director, Colon and Rectal Cancer Center,
Director, Young-Onset Colorectal Cancer Center,
Director of Clinical Research, Gastrointestinal Cancer Center,
Physician, Dana-Farber Cancer Institute
Paul Nguyen, MD
Associate Professor of Radiation Oncology, Harvard Medical School;
Genitourinary Clinical Center Director, Radiation Oncology,
Senior Physician,
Dana-Farber Cancer Institute;
Brigham and Women’s Hospital
Geoffrey Oxnard, MD
Associate Professor of Medicine, Harvard Medical School;
Physician, Dana-Farber Cancer Institute
Jonathan Schoenfeld, MD, MPhil, MPH
Assistant Professor of Radiation Oncology, Harvard Medical School;
Director, Melanoma Radiation Oncology
Physician, Dana-Farber Cancer Institute;
Brigham and Women’s Hospital
Partners HealthCare System is accredited by the Accreditation Council for Continuing Education to provide medical education for physicians.
Partners HealthCare System designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 5.50 AMA PRA Category 1 Credit™
- 5.50 Participation
Price
Our Course Coordinator can assist you with any special needs (i.e., physical, dietary, etc). Please contact Althea Luhm prior to the live event at 617-632-5473.
If you are having difficulty registering for the event, please reach out to the Partners Office of Continuing Professional Development at partnerscpd@partners.org
| Full Tuition | $50 |
Cancellation Policy:
Registrations cancelled on or before September 21, 2019 will be refunded, less a $15 administrative fee. Registrations cancelled after September 21, 2019 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.